But generics, unfazed by front-facing disclosure that their products ‘can cause psychiatric and/or sexual disorders,’ stay put May 31, 2023 Dear Friends: French resistance to burying Propecia’s sexual and neuropsychiatric side effects apparently proved too much for the medication’s manufacturer. Last week, drug-regulatory authority ANSM issued a news update (English) noting that Organon & Co. (NYSE: […]
Tag Archives: ANSM
French Drug-Regulatory Authority Unveils World’s Most Thorough PFS-Prevention Program
‘How-to’ video encourages reporting of finasteride ADRs to Ministry of Health July 13, 2022 Dear Friends: France’s National Agency for the Safety of Medicines and Health Products (ANSM) last week published a dossier of educational materials on the growing number of adverse drug reactions (ADRs) to finasteride 1 mg, as experienced by men currently suffering […]
PFS Awareness Unfurling at a Furious Pace in France
April 29, 2019 Dear Friends: The French are not fond of finasteride. March brought a barrage of media coverage in the nation’s escalating efforts to warn citizens against the medication’s potential dangers. On the broadcast front, three network news programs highlighted the suffering of PFS patients. In a segment on the France 5 program Allo […]
PFS is Front-page News in the Netherlands
February 25, 2019 Dear Friends: PFS awareness is fanning out across Europe faster than a leaky dyke. The latest nation to take up our charge is the Netherlands, via its second-largest newspaper, De Volkskrant, which boasts a daily circulation of more than 250,000. In a 2,600-word story that ran last week, reporter Irene de Zwaan […]
French Urologist to Top TV News Mag: Propecia is a potentially dangerous drug—’I even told my brother-in-law to stop taking it’
February 10, 2019 Dear Friends: Vive la France! This time we call your attention to a PFS report last week on 66 Minutes, which models itself after the iconic American news magazine 60 Minutes and boasts a Sunday-evening audience of two million viewers. The 14-minute segment, titled Is This Hair-loss Drug Dangerous? (English-subtitled version here), […]
Regulatory Update: France’s FDA-Equivalent Agency Reissues Finasteride Warning
February 2, 2019 Dear Friends: Prompted by an increasing number of adverse drug-reaction reports to finasteride, France’s FDA-equivalent agency yesterday issued a letter to 100,000 health professionals reminding them that patients treated with the drug are at risk for developing psychiatric disorders and persistent sexual disorders. The Agence Nationale de Sécurité du Médicament et des […]